E
The startup operates a medical technology platform focused on developing an oral investigational medicine that inhibits cancer cell division. This approach aims to provide healthcare professionals with additional treatment options for various cancer indications, ultimately demonstrating clinical proof-of-concept for efficacy in cancer patients.
Montréal, Canada
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a medical technology platform focused on developing an oral investigational medicine that inhibits cancer cell division. This approach aims to provide healthcare professionals with additional treatment options for various cancer indications, ultimately demonstrating clinical proof-of-concept for efficacy in cancer patients.